Breast Parallel Session 1

Friday, March 24, 2023

4:30 PM – 6:00 PM

Location:Veterans Memorial Auditorium

Moderator(s)

Andrea Abbott, MD, MSCR (she/her/hers)

Associate Professor of Surgery, Director Comprehensive Breast Program, Medical Director Cancer Quality
Medical University of South Carolina, United States

Disclosure(s): No financial relationships to disclose
Miral Amin, MD

Medical Director of Breast Cancer Center
John Peter Smith Hospital, Fort Worth, Texas
Southlake , Texas, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Andrea Abbott, MD, MSCR: No financial relationships to disclose

Miral Amin, MD: No financial relationships to disclose

Presentations:

4:31 PM – 4:41 PM

4: Germline Genetic Mutations in a Prospective Multi-Center Cohort of 241 Phyllodes Tumors; Time to Expand Testing Criteria
Abstract Presenter: Laura H. Rosenberger, MD, MS (she/her/hers) – Duke University Medical Center
Author: Laura H. Rosenberger, MD, MS (she/her/hers) – Duke University Medical Center
Author: Samantha M. Thomas, MS – Biostatistics and Bioinformatics, Duke University
Author: Tina J. Hieken, MD – Mayo Clinic
Author: Kristalyn K. Gallagher, DO (she/her/hers) – University of North Carolina at Chapel Hill
Author: Heather B. Neuman, MD, MS – University of Wisconsin School of Medicine and Public Health
Author: Anna Weiss, MD – Brigham and Women's Hospital
Author: Tari A. King, MD, FSSO, FASCO (she/her/hers) – Brigham and Womens Hospital, Dana Farber/Brigham Cancer Center
Author: Jasmine Wong, MD – Department of Surgery, University of California, San Francisco
Author: Barry S. Tong, MS, MPH – University of California, San Francisco
Author: Amanda L. Nash, MD – Duke University School of Medicine
Author: Carolyn S. Menendez, MD – Department of Surgery, Duke University
Author: Shelley Hwang, MD MPH – Duke University
Author: James W. Jakub, MD – Mayo Clinic
Author: Jennifer K. Plichta, MD, MS – Duke University Medical Center
4:41 PM – 4:51 PM

5: Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection
Abstract Presenter: Shruti Zaveri, MD MPH (she/her/hers) – MD Anderson Cancer Center
Author: Shruti Zaveri, MD MPH (she/her/hers) – MD Anderson Cancer Center
Author: Elizabeth FitzSullivan, MD – The University of Texas MD Anderson Cancer Center
Author: Rosa Hwang, MD – The University of Texas MD Anderson Cancer Center
Author: Benjamin D. Smith, MD – The University of Texas MD Anderson Cancer Center
Author: Heather Lin, PhD – MD Anderson Cancer Center
Author: Yu Shen, PhD – MD Anderson Cancer Center
Author: Anthony Lucci, Jr., MD – The University of Texas MD Anderson Cancer Center
Author: Mediget Teshome, MD, MPH, FACS (she/her/hers) – The University of Texas MD Anderson Cancer Center
Author: Susie Sun, MD – MD Anderson Cancer Center
Author: Kelly K. Hunt, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center
Author: Henry M. Kuerer, MD, PhD – The University of Texas MD Anderson Cancer Center
4:51 PM – 5:01 PM

6: Population-based survival outcomes of pure vs mixed invasive Lobular Breast Carcinoma in Ontario, Canada
Abstract Presenter: David W. Lim, MDCM, MEd, PhD – Women's College Research Institute, Women's College Hospital & University of Toronto Department of Surgery
Author: David W. Lim, MDCM, MEd, PhD – Women's College Research Institute, Women's College Hospital & University of Toronto Department of Surgery
Author: Vasily Giannakeas, PhD – Women's College Research Institute
Author: Steven Narod, MD – Women's College Research Institute
Author: Kelly Metcalfe, RN PhD – Women's College Research Institute
5:01 PM – 5:11 PM

7: Multicenter clinical trial for omission of breast surgery in invasive cancer following neoadjuvant systemic therapy: Longitudinal patient reported outcomes and decisional comfort planned analyses
Abstract Presenter: Helen M. Johnson, MD (she/her/hers) – MD Anderson Cancer Center
Author: Emilia Diego, MD – University of Pittsburgh
Author: Savitri Krishnamurthy, MD – MD Anderson Cancer Center
Author: Wei Yang, MBBS MHM – MD Anderson Cancer Center
Author: Benjamin D. Smith, MD – The University of Texas MD Anderson Cancer Center
Author: Vincente Valero, MD – MD Anderson Cancer Center
Author: Anthony Lucci, Jr., MD – The University of Texas MD Anderson Cancer Center
Author: Simona Shaitelman, MD EdM – MD Anderson Cancer Center
Author: Melissa Mitchell, MD PhD – MD Anderson Cancer Center
Author: Judy C. Boughey, MD, FACS, FSSO (she/her/hers) – Mayo Clinic
Author: Richard L. White, MD – Atrium Health-Levine Cancer Institute
Author: Gaiane Rauch, MD PhD – MD Anderson Cancer Center
Author: Henry M. Kuerer, MD, PhD – The University of Texas MD Anderson Cancer Center
5:11 PM – 5:21 PM

8: De-escalation of Post-Mastectomy Irradiation in Hormone Receptor-Positive Breast Cancer with One to Three Positive Nodes
Abstract Presenter: Gili G. Halfteck, MD, PhD (she/her/hers) – University of Texas Medical Branch
Author: Gili G. Halfteck, MD, PhD (she/her/hers) – University of Texas Medical Branch
Author: Efstathia Polychronopoulou, MsC – University of Texas Medical Branch
Author: Waqar Haque, MD – University of Texas medical Branch
Author: Roi Weiser, MD – University of Texas Medical Branch
Author: Sandra S. Hatch, MD – University of Texas Medical Branch
Author: Suzanne Klimberg, MD PhD MSHCT MAMSE – UTMB, MDACC
5:21 PM – 5:31 PM

9: Breast cancer-related lymphedema and its relationship to major landmark trials in surgical oncology and radiation oncology
Abstract Presenter: Robert M. Pride, MD – Dana Farber Cancer Institute/Brigham & Women's Hospital/Massachusetts General Hospital
Author: Robert M. Pride, MD – Dana Farber Cancer Institute/Brigham & Women's Hospital/Massachusetts General Hospital
Author: Michelle C. Specht, MD – Massachusetts General Hospital
Author: George Naoum, MD MMSCI – Northwestern University Memorial Hospital
Author: Brooke C. Juhel, n/a – Massachusetts General Hospital
Author: Cheryl L. Brunelle, PT MS CCS CLT – Massachusetts General Hospital
Author: Amy M. Shui, n/a – Massachusetts General Hospital
Author: Charity C. Glass, MD MPP – Dana-Farber Cancer Institute/ Brigham & Women's Hospital/ Massachusetts General Hospital
Author: Alphonse G. Taghian, MD PHD – Massachusetts General Hospital
5:31 PM – 5:41 PM

10: Epigenetic Drug Therapy Increases Immune Activation and Expression of Genes in the Oncotype Dx Score in Breast Cancer
Abstract Presenter: Rebecca M. Platoff, MD, MSc (she/her/hers) – Cooper University Hospital
Author: Rebecca M. Platoff, MD, MSc (she/her/hers) – Cooper University Hospital
Author: Ping Zhang, PhD – Cooper University Hospital Department of Surgery
Author: Jaroslav Jelinek, MD PhD – Coriell Institute for Medical Research
Author: Jozef Madzo, PhD – Coriell Institute for Medical Research
Author: Gennaro Calendo, MS – Coriell Institute for Medical Research
Author: Matthew Walt, MS – Coriell Institute for Medical Research
Author: Umur Atabek, MD – Cooper University Hospital Department of Surgery
Author: Francis R. Spitz, MD – Cooper University Hospital
Author: Young K. Hong, MD,MPH,FACS,FSSO – Cooper University Hospital
5:41 PM – 5:51 PM

11: Genomic Landscape of Malignant Phyllodes Tumors Reveals Multiple Targetable Opportunities
Abstract Presenter: Laura H. Rosenberger, MD, MS (she/her/hers) – Duke University Medical Center
Author: Laura H. Rosenberger, MD, MS (she/her/hers) – Duke University Medical Center
Author: Richard F. Riedel, MD – Duke Univesity Medical Center
Author: Emilia Diego, MD – University of Pittsburgh
Author: Natalie A. Danziger, BS – Foundation Medicine Inc
Author: Ethan Sokol, PhD – Foundation Medicine Inc
Author: Jeffrey S. Ross, MD – Foundation Medicine Inc
Author: Sarah L. Sammons, MD – Duke University